A study in the current issue of the New England Journal of Medicine shows a serious complication of ERCP, a procedure commonly used to diagnose and treat problems of the bile and pancreatic ducts, may be eliminated with a single dose medication.

An updated study gives new information on the cardiovascular risks of non-steroidal anti-inflammatory drugs (NSAIDs) and suggests that naproxen, a commonly used drug, and low dose ibuprofen are least likely to increase cardiovascular risks.

BEDFORD, Ohio, June 13, 2011 /PRNewswire/ -- On April 19, 2011, Bedford Laboratories(TM), a division of Ben Venue Laboratories, Inc., initiated a nationwide voluntary recall of the following product: (Logo: http://photos.prnewswire.com/prnh/20070809/CLTH157LOGO ) Indomethacin for Injection, USP, 1mg Single Dose Vial NDC #55390-299-01, Lot 1948138, Exp.

HONG KONG, March 24 /PRNewswire-FirstCall/ - AlphaRx Inc. (OTC BB:ALRX.OB) has received a Notice of Allowance from the United States Patent and Trademark Office for its lead pain product candidate code named ARX8203, a potentially safer drug intended for pain treatment.

TARRYTOWN, N.Y., June 9 /PRNewswire-FirstCall/ -- Regeneron Pharmaceuticals, Inc.